News from Illinois CancerCare

Breast Cancer Weight Loss Study

Are you a patient with breast cancer interested in a weight loss program?
If you are, you may be able to help researchers answer an important question: Does losing weight by eating less and exercising lower the risk of cancer recurrence among women who have been diagnosed with early breast cancer? The BWEL Breast Cancer Weight Loss Study aims to answer this question.

What does the study involve?
Participants will be randomly assigned (like the flip of a coin) to one of two groups:

  • Weight Loss Intervention Group – Takes part in a telephone-based weight loss program
  • Health Education Group – Receives mail or online information about breast cancer topics

What is required?
Participation in this study involves completing health questionnaires and taking weight measurements and a fasting blood draw at different points throughout.

Who can participate in the study?
You may be eligible to participate if:

  • You have been diagnosed with stage II-III breast cancer in the last 14 months
  • You have completed surgery, radiation and chemotherapy (if applicable)
  • You are interested in taking part in a weight loss program

Who is conducting this study?
This study is being conducted by the Alliance for Clinical Trials in Oncology. The Alliance is part of a national research network funded by the National Cancer Institute (NCI).

For more information, please contact the Illinois CancerCare Research Department at 309-243-3605 or